Elevated concentrations of dyshaemoglobins such as methaemoglobin (metHb), carboxyhaemoglobin (COHb) or sulphhaemoglobin (SHb) limit the oxygen-carrying capacity of arterial blood and can cause misinterpretation of oxygen status when the level of functional oxygen saturation provided by most blood gas analysers is used for patient evaluation. These haemoglobin (Hb) fractions are not detected by blood gas analysis, and require a specially designed spectrophotometer called a co-oximeter. We report on the performance of dyshaemoglobin measurements using a combined-function analyser (ABL 520 pH/blood gas analyser, Radiometer, Westlake, OH, USA) and compare it with a dedicated co-oximeter (AVL 912 Co-Oxylite, AVL Scientific Corporation, Roswell, GA, USA).
MATERIALS AND METHODS
Methaemoglobin samples were prepared in the laboratory by treating 0·5 mL of red blood cells from EDTA blood with 200 J1L 0·18 rnol/L sodium nitrite for 15 min. The oxidized cells were washed three times with 3 mL of 0·9% sodium chloride and reconstituted with O· 5 mL of plasma. The metHb concentration of samples prepared in this way varied between 11·2 and 14·2 g/dl, (76-96% total Hb). Samples with the desired metHb concentration were obtained by dilution with untreated EDTA blood and analysed within I h of preparation.
Correspondence: Ms SF Lim. E-mail: gptlsf@sgh.gov.sg 774 Carboxyhaemoglobin was prepared from EDTA blood by bubbling town gas (containing significant amounts of carbon monoxide) until the blood turned cherry red. The COHb concentration of samples prepared in this way varied between 11·8 and 14·7g/dL (80-100% total Hb). Samples with the desired COHb concentration were obtained by dilution with untreated EDTA blood and analysed within I h of preparation.
Dipotassium EDTA, lithium heparin and fluoride/heparin vacutainer tubes were obtained from Becton/Dickinson Vacutainer Systems (Franklin Lakes, NJ, USA). Potassium oxalate tubes were prepared by adding 2 mg of the anticoagulant per mL of blood. Blood with varying concentrations of metHb (0' 3-11'8 g/dL, 2-80% total Hb) and COHb (0'3-8'88g/dL, 2-60% total Hb) was aliquoted into each of the above anticoagulated tubes and the metHb and COHb content measured on the ABL 520 after 0, I, 2, 3, 4 and 18 h. All samples were stored at
4°C.
Specimens (0'5 mL whole blood) for wavelength scanning were haemolysed with 3-5 mg of saponin. After dilution with 4·5 mL of 0·1 mol/L phosphate buffer (pH 7-4) and centrifugation to remove cellular debris, the diluted haemolysate was scanned for its absorbance between 500 and 700 nm on a Beckman DU-70 spectrophotometer (Beckman Instruments Inc, Fullerton, CA, USA).
Equipment
The ABL 520 pH/blood gas analyser consists of a conventional blood gas analyser plus a cooximeter, whereas the AVL 912 Co-Oxylite is a dedicated co-oximeter. In the co-oximeter, blood is haemolysed in a cuvette by ultrasonication and the absorbance is measured at five different wavelengths: 535, 560, 577, 622 and 636 nm for COHb, reduced Hb (RHb), oxyhaemoglobin (02Hb), SHb and metHb, respectively. The concentration of each haemoglobin fraction is determined from the measured absorbance by multi-component analysis built into the systems. The whole measuring cycle takes 1·5 min.
Total haemoglobin (tHb) concentration, functional oxygen saturation (functional S02) and fractional oxygen saturation (fractional S02) were derived from the measured parameters using the following equations:
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The AVL 912 reports both the functional S02 and fractional S02 but the ABL 520 reports only the functional S02' which can lead to misinterpretation of oxygen status when the level of any of the dyshaemoglobins is increased. Due to the confusion that may arise from these definitions, both the NCCLS) (National Committee on Clinical Laboratory Standards) and the IFCC 2 (International Federation of Clinical Chemistry) have recommended the use of the term 'oxygen saturation' for functional S02 and 'fractional oxyhaemoglobin' for fractional S02' The difference between these definitions can affect clinical decisions in patients with methaemoglobinaemia or carboxyhaemoglobinaemia,' and fractional oxyhaemoglobin should be used for complete assessment of oxygen status.
RESULTS AND DISCUSSION
Patients' samples were used for tHb studies and laboratory prepared samples were used for metHb and COHb studies. Table 1 shows the within-run precision of tHb, metHb and COHb measured on the ABL 520 and the AVL 912. Precision was poor at metHb and COHb concentrations below 0·13 g/dL, but this is considered clinically acceptable because levels below 0·27 g/dL are considered normal." Accuracy studies of tHb, metHb and COHb The accuracy of tHb measurements was assessed by comparing results on the ABL 520 and AVL 912 with the conventional hemiglobincyanide method on the Technicon H-I analyser (Bayer Diagnostics, Tarrytown, NY, USA) using patients' specimens with tHb concentrations ranging from 6 to 19 g/dl., Correlation coefficients of 0·99 and 0·99, respectively, were obtained (intercept = O' 36 g/dL, slope = 0,98, n = 31 for ABL 520; intercept = O'32 g/dL, slope = 1·00, n=26 for AVL 912).
Precision of tHb, metHb and COHb measurement
The accuracy of metHb measurement was assessed by comparing metHb measurements on the ABL 520 with those by the manual quantitative method.' A correlation coefficient of 0·99 was obtained (constant = -0·09 g/dl., slope = 0,94, n = 20, metHb range 0-7·49 g/dl, or 0-50'6%). MetHb measurements on the ABL 520 correlated well with those on the AVL 912 (r = 0,99, constant = 0·04 g/dL, slope = 0·97, n = 28, metHb range = 0-9·47 g/dL or O-M%).
The accuracy of COHb measurement was assessed by comparing results on the ABL 520 with expected values obtained from serial dilutions of a laboratory-prepared COHb sample (13'6 g/dl.), A correlation coefficient of 0·99 was obtained (intercept = -0·16 g/dl., slope = 0-96, n = 20). COHb measurements on the ABL 520 and those on the AVL 912 correlated well (r=0·99, intercept = -0·30g/dL, slope = 1-09, n=26, COHb range = 0-3-14'2g/dL or 2-96%). Effect of anticoagulants on metHb and COHb The metHb content of blood anticoagulated with dipotassium EDTA, lithium heparin or potassium oxalate decreased gradually with time; after 2 h, metHb content was found to be 88-93% of its initial value and after 18 h it was 63-69% of its initial value. In fluoride/heparin tubes metHb disappeared rapidly and the metHb content was only 0--1 % of the initial level immediately after adding the blood. An absorbance scan of this specimen showed that the metHb peak at 636 nm was absent, but a new peak at 600 nm was observed. When aliquots of a sample containing 13'6g/dL oftHb and 0'2g/ dL of metHb (1'5% total Hb) were placed in fluoride/heparin and EDTA tubes and measured on the ABL 520, the concentrations of tHb and all Hb fractions in the two tubes were identical. However, in a sample containing 13·8 g/dL of tHb and 12·6 g/dl, ofmetHb (91% total Hb) in a fluoride/heparin tube, measured values of tHb and metHb were reduced to 7·1 g/dl, and 0·9 g/ dL, respectively, while other Hb fractions were slightly elevated. It appears that fluoride reacted with metHb, causing a change in the metHb absorption spectrum resulting in altered values of tHb and Hb fractions. The COHb content in all four anticoagulants did not show any appreciable change over the 18-h period; at 2 h the COHb content ranged between 96 and 98% of its initial value and at 18 h it fell to 90--95% of its initial value.
CONCLUSION
The ABL 520 and the AVL 912 were found to provide rapid and reliable results for assays of tHb and Hb fractions. While the ABL 520 does not report actual SHb values, it provides a reliable indication of SHb presence and has been considered adequate] since sulphaemoglobinaemia is rarely encountered in clinical practice. The limits of the measuring systems -up to 10 g/ dL for metHb (67% for tHb of 15 g/dl.) and up to 14·7 g/dl, for COHb (98% for tHb of 15 g/ dL) -were found to be adequate for most Ann Clin Biochem \999: 36 clinical situations. The small volumes required for co-oximetry (35 J1L for ABL 520 and 40 J1L for AVL 912) allow for continuous monitoring of patient status with minimal blood loss.
Methaemoglobin is unstable as it can be converted enzymatically to Hb and becomes OzHb if measurement is delayed. We have found that metHb is stable for up to 2 h in dipotassium EDTA, lithium heparin or potassium oxalate as anticoagulants. Fluoride should not be used because of its interaction with metHb, resulting in falsely low tHb and metHb levels. COHb was found to be relatively stable in all four anticoagulants tested.
